| Literature DB >> 36234942 |
Pooja Salve1, Aruna Vinchurkar1, Rajesh Raut2, Ramesh Chondekar3, Jaya Lakkakula4, Arpita Roy5, Md Jamal Hossain6, Saad Alghamdi7, Mazen Almehmadi8, Osama Abdulaziz8, Mamdouh Allahyani8, Anas S Dablool9, Md Moklesur Rahman Sarker6, Mohd Fahami Nur Azlina10.
Abstract
In the current decade, nanoparticles are synthesized using solvents that are environmentally friendly. A number of nanoparticles have been synthesized at room temperature using water as a solvent, such as gold (Au) and silver (Ag) nanoparticles. As part of nanotechnology, nanoparticles are synthesized through biological processes. Biological methods are the preferred method for the synthesis of inorganic nanoparticles (AgNPs) as a result of their simple and non-hazardous nature. Nanoparticles of silver are used in a variety of applications, including catalysts, spectrally selective coatings for solar absorption, optical objectives, pharmaceutical constituents, and chemical and biological sensing. Antimicrobial agents are among the top uses of silver nanoparticles. In the current study, silver nanoparticles were biologically manufactured through Madhuca longifolia, and their antibacterial activity against pathogenic microorganisms, anticancer, anti-inflammatory, and antioxidant activities were assessed. UV-Vis spectroscopy, XRD (X-ray diffraction), transmission electron microscopy, Zeta Potential, and FTIR were used to characterize silver nanoparticles. The current work describes a cheap and environmentally friendly method to synthesize silver nanoparticles from silver nitrate solution by using plant crude extract as a reducing agent.Entities:
Keywords: Madhuca longifolia; anti-inflammation; antibacterial; anticancer; antioxidation; silver nanoparticle
Mesh:
Substances:
Year: 2022 PMID: 36234942 PMCID: PMC9572794 DOI: 10.3390/molecules27196404
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1UV-Vis spectra of reaction mixture and control recorded after 5 min of exposure to sunlight.
Figure 2FTIR spectrum of Madhuca longifolia leaf extract.
Figure 3FTIR spectrum of AgNps synthesized by Madhuca longifolia leaf extract.
Figure 4TEM images of AgNps synthesized using dried leaf extract M. longifolia insight Selected Area Electron Diffraction (SAED) pattern of AgNPs.
Figure 5(a) XRD pattern for synthesized silver nanoparticles (b) Pattern from JCPDS file No. 04-078.
Figure 6Size distribution of silver nanoparticles.
Figure 7Zeta potential for silver nanoparticles.
Antimicrobial activity of M. longifolia Leaf Nanoparticles.
| Name of Organism | STANDARD | |||||
| 50 | 100 | 150 | 200 | 250 | ||
| Zone of inhibition in mm including disk (AgNPs) | 10 | 11 | 13 | 16 | 20 | 20 |
| Zone of inhibition in mm including disk (Crude) | − | 10 | 13 | 13 | 14 | 22 |
Anti-inflammatory activity of silver nanoparticles studied using BSA denaturation method.
| Concentration of AgNps (μg/mL) | Percent inhibition | |
| Sodium Diclofenac | AgNps | |
| 100 | 21.48 ± 0.51 | 20.60 ± 0.22 |
| 200 | 28.17 ± 0.78 | 23.80 ± 0.41 |
| 300 | 33.28 ± 1.12 | 33.17 ± 1.35 |
| 400 | 42.16 ± 0.31 | 39.48 ± 0.26 |
| 500 | 56.68 ± 0.92 | 53.15 ± 0.87 |
Effect of different concentrations of AgNPs and standard (sodium diclofenac) on HRBC membrane hemolysis of erythrocyte using heat-induced and hypotonicity studies.
| Treatment(s) | Concentration (μg/mL) | Absorbance at 560 nm | %Inhibition of hemolysis | ||
| For Heat-induced studies | For Hypotonicity induced studies | For Heat-induced studies | For Hypotonicity induced studies | ||
| Control | − | 0.32 | 0.33 | − | − |
| 100 | 0.39 | 0.42 | 21.87 | 27.27 | |
| 200 | 0.24 | 0.40 | 25 | 21.21 | |
| 300 | 0.20 * | 0.24 NS | 37.5 | 27.27 | |
| 400 | 0.18 * | 0.21 NS | 43.75 | 36.36 | |
| 500 | 016 NS | 0.14 NS | 50 | 57.57 | |
| Sodium Diclofenac | 100 | 0.08 | 0.13 | 75 | 60.60 |
SE = of six individual observations, * values are significant at P < 0.001, NS = non-significant.
Figure 8TLC-DPPH assay of M. longifolia leaf extract after spraying DPPH.
Percent scavenging activity showed by AgNPs and ascorbic acid.
| Concentration (μg/mL) | DPPH% Scavenging activity | ||
| AgNps | Crud extract of leaf | Ascorbic acid | |
| 100 | 7.6 * | 7.0 | 78 |
| 200 | 14.33 * | 10.89 | 80 |
| 300 | 23.33 * | 16.00 | 82 |
| 400 | 24.33 * | 20.45 | 83 |
| 500 | 29.66 | 22.18 | 84 |
SE= of six individual observations, * values are significant at P < 0.005 and P < 0.001.
Anticancer activities of silver nanoparticles and control (ADR).
|
|
| |||
|
| ||||
| 10 | 20 | 40 | 80 | |
| Silver nanoparticles | 96.4 | 105.6 | 107.9 | 133.5 |
| ADR | −51.2 | −27.6 | −34.5 | −23.1 |
|
| ||||
| Silver nanoparticles | 104.5 | 99.8 | 82.8 | 53.7 |
| ADR | −48.0 | −55.6 | −56.7 | −49.9 |
|
|
|
| ||
|
| ||||
| LC 50 | TGI | GI50 | ||
| Silver nanoparticles | >100 | >100 | >80 | |
| ADR | 52.5 | <10 | <10 | |
|
| ||||
| Silver nanoparticles | >100 | >100 | >80 | |
| ADR | 44.1 | <10 | <10 | |
LC50 = Concentration of drug causing 50% cell kill; GI50 = Concentration of drug causing 50% inhibition of cell growth; TGI = Concentration of drug causing total inhibition of cell growth; ADR = Adriamycin, Positive control compound.